Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Celiac Disease Genomic Environmental Microbiome and Metabolomic Study

Key facts

Where
Boston, United StatesSee the site

Where in United States

  • MassGeneral Hospital for ChildrenBoston, United StatesContact: Victoria Kenyon, MHATaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Massachusetts General Hospital
Trial code
NCT02061306
Record updated
30 October 2026
Original description
Celiac disease (CD) is a complex disease caused by eating gluten, a protein contained in wheat, rye, and barley. It is well known that many factors contribute to the development of CD, including the genes that you have and the foods that you eat. In the CDGEMM study, we will consider as many of these factors as possible and study how they each contribute to disease development. If the investigators find that any one factor, or combination of factors, increases the risk of developing CD, we will be able to apply this information and help prevent or detect disease in high-risk children in the future.Read full original descriptionShow less

Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study

Celiac disease (CD) is a complex disease caused by eating gluten, a protein contained in wheat, rye, and barley. It is well known that many factors contribute to the development of CD, including the genes that you have and the foods that you eat. In the CDGEMM study, we will consider as many of these factors as possible and study how they each contribute to disease development. If the investigators find that any one factor, or combination of factors, increases the risk of developing CD, we will be able to apply this information and help prevent or detect disease in high-risk children in the future.

Inclusion: Newborns and infants less than 6 months of age who have not been introduced to solid foods (exclusive breast milk or formula diet); First-degree relatives of patients affected with biopsy-proven CD.

Exclusion: Infants older than 6 months of age; Inability or unwillingness of legal guardian/representative to give written informed consent.

ClinicalTrials.gov NCT02061306